Many thanks to the original poster, just highlighting the canary letter advising that final approval has been given by SEC for January listing in NASDAQ after institutional investors return back from Christmas break ,(institutional investors) wink wink. also results from phase 2 sleep apnea is expected late January, how good are the results you ask ? a meeting with FDA is being scheduled wink wink. Canary tends to release such letters only when there is something worth it, they dont release such reports often so your call, get those share while they are still hovering around 50 OZ cents
IHL Price at posting:
50.5¢ Sentiment: Hold Disclosure: Held